logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table HSR-3. Estimated number of clients in methadone treatment and of clients receiving any opioid substitution [see all tables in this series...]

Part (iii) Methodological notes EU-27, Croatia, Turkey and Norway, 2003–07

BelgiumEstimate for 2003 based on client numbers in 2001/2002 and 2005 (mean). From 2005 onwards, data from substitution register are available. Foreign clients treated in Belgium (mainly French) not included.
Czech RepublicFor 2005, data from psychiatric outpatient units were not available. Data for 2005 are an estimate, based on the most recent data available from such units. Data for 2007 include clients treated at specialised substitution centres and an estimate of the total number of buprenorphine clients.
Denmark2003-2005: Data refer to clients in long-term (> 5 months) methadone treatment and do not include clients treated in prisons. 2007 data: 2004 estimates, personal communication, K Grasaasen, NFP Denmark, 24 February 2009
GermanyCensus data 1 July (national substitution register), double-counting is not totally excluded.
EstoniaEstimated number of individual clients in methadone substitution treatment based on data collected through routine reporting from 6 treatment centres funded through NIHD.
Ireland2003 and 2005: Data on methadone treatment clients in prison not included. These were 1477 cases in 2003 and 1295 in 2005. 2007 data: Based on the Central Treatment List held by the Drug Treatment Centre Board on behalf of the HSE and on the National Drug Treatment Reporting System (NDTRS). This calculation attempts to exclude detoxifications.
GreeceFocal Point Data collection based on TUF questionnaire.
SpainData do not include substitution treatment provided to drug users in prisons (around 20.000 treatments per year).
FranceOFDT estimations, based on data survey on substitute prescribing performed by the Institut de Veille Sanitaire and on social security reimbursement statistics for substitution medications; personal communication, T. Canarelli, 12 March 2007
Italy2003: based on data from 520 out of 562 SerT. 2005: based on national survey. 2007: estimates.
CyprusThe above estimate is based on key experts information and on the treatment demand monitoring system.
LithuaniaCentral database on treatment covering mainly public healthcare institutions; private treatment underreported.
HungaryExact data arrived from 10 treatment providers in 2007. (for more details - see chapter 5 of NR 2008)
Malta2003-2005: Only clients registered at centralised methadone dispensing unit who received prescriptions for more than 3 months. Prison, GPs not included.
NetherlandsNumbers include clients in outpatient addiction care treated with methadone and diamorphine treatments. 2007 data: estimate of methadone clients.
AustriaA distinction of cases by substance is not possible in Austria.
PolandThe number of clients is given by substitution programmes on special request of National Bureau for Drug Prevention.
PortugalData on methadone treatments are based on census in public treatment system (CATs) each 31 December. Clients treated under responsibility of Prison Services (345 in 2003 and 271 in 2005) not included.
SloveniaData for 2007: based on registry which covers 17 of 19 treatment centres.
SlovakiaData for 2005: Personal communication Slovakia NFP, 14 March 2007.
FinlandFor 2005, estimated proportion of methadone clients among all substitution clients in Finland as reported by Partanen A, Development of Low Threshold Services, Hapkohet No. 5, 2006, pp 58-59. Ratio reported in NR 2005 p. 74. Data reported under 2007 are based on an expert estimate for 2007-2008. Personal communication Sanna Rönkä, NFP Finland, 13 March 2009.
UK- EnglandData represent the number of people being prescribed for as part of structured treatment according to National Drug Treatment Monitoring System (www.ndtms.net). Actual numbers of clients are not available but a large majority of prescribing will be for opiate use, and of this a large majority will be for methadone, although there is growing use of buprenorphine. The figures will overestimate the extent of substitute prescribing. Client numbers refer to UK fiscal years 1 April (of the reporting year) to 31 March following calendar year.
UK-Northern Irel.Data refer to fiscal years 1 April (of the reporting year) to 31 March of following calendar year.
CroatiaClients in substitution maintenance programmes.
NorwayBased on annual report of treatment centres.

Page last updated: Friday, 20 November 2009